Thursday, August 7, 2014

Best Mid Cap Stocks To Invest In Right Now

Small cap apparel stock G-III Apparel Group, Ltd (NASDAQ: GIII) has been making bullish moves lately plus the stock is up 97.1% since the start of the year, making it the third best performing apparel stock (according to stock screener Finviz)�after small cap�Ever-Glory International Group Inc (NYSEMKT: EVK) and mid cap Fifth & Pacific Companies Inc (NYSE: FNP) followed by mid cap Hanesbrands Inc (NYSE: HBI). But is the G-III Apparel Group dressed for long term success for investors?

What is the G-III Apparel Group

Tracing its roots back to 1956 when Holocaust survivor Aron Goldfarb immigrated to the United States and established his own outerwear company located in the heart of New York City�� Garment District, small cap�G-III Apparel Group G-III has a comprehensive portfolio of over 30 licensed and proprietary brands, including Calvin Klein, Kenneth Cole, Cole Haan, Guess?, Tommy Hilfiger, Levi��, Dockers, Jessica Simpson, Vince Camuto, Ellen Tracy, Kensie, Mac & Jac, Jones New York, Ivanka Trump, Sean John, Nine West and G.H. Bass, among others plus the company�operates retail stores under the Wilsons Leather, Bass, G.H. Bass & Co., Vilebrequin, Calvin Klein Performance and Andrew Marc names.�In addition, G-III Apparel Group has licenses with the four major professional sports leagues, as well as over 100 US�colleges and universities. G-III Apparel Group also�designs, manufactures and markets an extensive range of apparel, including outerwear, dresses, sportswear, beachwear, women�� suits and women�� performance wear�plus luggage and women�� handbags, small leather goods and various accessories.

Top 5 Heal Care Stocks To Own Right Now: Broadridge Financial Solutions Inc (BR)

Broadridge Financial Solutions, Inc. (Broadridge), incorporated on March 29, 2007, is a global provider of investor communications and technology-driven solutions to banks/broker-dealers, mutual funds and corporate issuers. The Company's systems and services include investor communication solutions, and securities processing and operations outsourcing solutions. It operates in two segments: Investor Communication Solutions and Securities Processing Solutions. The Company provides the infrastructure that helps the financial services industry operate. It serves a client base across its four businesses: Bank/Broker-Dealer Communications, Mutual Fund and Retirement Solutions, Corporate Issuer Solutions, and Bank/Broker-Dealer Technology and Operations. It delivers a range of solutions that help its clients serve their retail and institutional customers across the entire investment lifecycle, including pre-trade, trade and post-trade processing. In February 2014, the Company announced that it has acquired Emerald Connect, LLC, a provider of websites and related communications solutions for financial advisors, from StoneRiver Group, L.P.

Investor Communication Solutions

The Company's Bank/Broker-Dealer Communications, Mutual Funds and Retirement Solutions and Corporate Issuer Solutions businesses operate within this segment. A large portion of the Company's Investor Communication Solutions business involves the processing and distribution of proxy materials to investors in equity securities and mutual funds, as well as the facilitation of related vote processing. ProxyEdge, its electronic proxy delivery and voting solution for institutional investors and financial advisors, helps ensure the participation of the stockholders of many companies. The Company also provides the distribution of regulatory reports and corporate action/reorganization event information, as well as tax reporting solutions that help its clients meet their regulatory compliance needs. In addition, it provides f! inancial information distribution and transaction reporting services to both financial institutions and securities issuers. These services include the processing and distribution of account statements and trade confirmations, traditional and personalized document fulfillment and content management services, marketing communications, and imaging, archival and workflow solutions that enable and enhance the Company's clients' communications with investors. All of these communications are delivered in paper or electronic form. In addition, Broadridge provides corporate issuers with registrar, stock transfer and record-keeping services.

The Company distributes more than one billion investor communications annually through a combination of physical and electronic channels. Through the Company's governance activities, Broadridge has a service relationship with every major mutual fund complex in the United States. Broadridge is an independent provider of retirement fund processing and provides data-driven market intelligence, specialized marketing communications and fund governance. Broadridge serves corporate issuers with a variety of their needs, including proxy and transfer agency services, both domestically and globally.

The Company provides proxy distribution, vote tabulation, and various additional investor communication tools and services to institutional investors, corporate issuers and investment companies. The Company handles the entire proxy materials distribution and voting processes for its bank and broker-dealer clients on-line and in real-time, from coordination with third-party entities to ordering, inventory maintenance, mailing, tracking and vote tabulation. It offers electronic proxy delivery services for the electronic delivery of proxy materials to investors and collection of consents; maintenance of a database that contains the delivery method preferences of its clients' customers; posting of documents on the Internet; e-mail notification to investors notifying th! em that p! roxy materials are available, and proxy voting over the Internet, mobile devices and tablets. The Company also provides a complete reorganization communications solution to notify investors of reorganizations or corporate action events, such as tender offers, mergers and acquisitions, bankruptcies and class action lawsuits.

The Company offers its bank and brokerage clients financial information distribution and transaction reporting services to help them meet their regulatory compliance requirements and business needs, including prospectus fulfillment services; electronic prospectus services; PostEdge, its electronic document archival and electronic delivery solution for documents, including trade confirmations, tax documents and account statements; marketing communications; imaging, archival and workflow solutions, and on-demand digital print services. In addition, the Company offers its Mailbox productsAdvisor Mailbox and Investor Mailbox, which provides a holistic network environment that support and complements any investor communication strategy. The Company's Advisor Mailbox is an electronic communications platform for financial advisors that delivers immediate electronic access to the communications and documents sent to such advisors' customers. Advisor Mailbox streamlines multiple communication paths for all investor-related documents into a single-visit portal that is integrated onto an advisor's platform.

The Company offers tax services to financial services firms that support their various information year-end reporting (e.g., Forms 1099) and withholding requirements, with a focus on securities and fund processing/clearance operations. The Company's tax data services provide tax content and data management, including securities tax classifications and reclassifications, calculations of original issue discount and other accrual and cost basis adjusting events. The Company's tax managed services provide technology and personnel outsourcing, withholding services and cl! ient repo! rting, including print/electronic distribution and archival.

The Company provides a suite of services to manage the entire proxy voting process of institutional investors, including fulfilling their fiduciary obligations and meeting their reporting needs, such as ProxyEdge, its workflow solution that integrates ballots for positions held across multiple custodians and presents them under a single proxy. ProxyEdge also provides for client reporting and regulatory reporting. ProxyEdge can be utilized for meetings of United States and Canadian companies and for meetings in many non-North American countries based on the holdings of the Company's global custodian clients. The Company is a processor and provider of investor communication solutions to public companies. It offers its corporate issuer clients many tools to facilitate their communications with investors, such as Internet and telephone proxy voting, electronic delivery of corporate filings, and householding of communications to stockholders at the same address. It also offers proxy services to non-North American corporate issuers in connection with their general and special meetings of stockholders. The Company's corporate issuers services include ShareLink, which provides complete project management for the beneficial and registered proxy process.

The Company's Shareholder Forum solution is an online venue that offers public companies the ability to host structured, controlled communication with their shareholders on a timely and regular basis. The Company's Virtual Shareholder Meeting service provides corporate issuers in a number of states with the ability to host their annual meeting electronically on the Internet, either on a stand-alone basis, or in conjunction with their physical annual meeting.

The Company provides a range of tools that enable mutual funds to communicate with audiences of investors and often with substantial cost savings. The Company's solutions allow mutual funds to centralize all in! vestor co! mmunications through one resource. The Company also provides printing and mailing of regulatory reports, prospectuses and proxy materials, as well as proxy solicitation services. In addition, it distributes marketing communications and informational materials and creates on-demand enrollment materials for mutual fund investors. Its position in the industry enables the Company to manage the entire communication process with both registered and beneficial stockholders. The Company's SalesVision platform provides data aggregation and data management solutions. SalesVision is software delivered as a service (SaaS) and assists mutual funds in processing commission and distribution payments, monitoring their compliance with regulatory requirements, and assembling shareholder and intermediary data in a form to better drive their sales strategy and marketing programs. The Company provides mutual fund processing services for third party administrators, financial advisors, banks and wealth management professionals through its subsidiary Matrix Financial Solutions, Inc.

Securities Processing Solutions

The Company's Bank/Broker-Dealer Technology and Operations business operates within this segment. The Company offers a suite of advanced computerized real-time transaction processing services that automate the securities transaction lifecycle, from desktop productivity tools, data aggregation, performance reporting, and portfolio management to order capture and execution, trade confirmation, settlement and accounting. The Company's services help financial institutions consolidate their books and records, gather and service assets under management, focus on their core businesses and manage risk. In addition, the Company's operations outsourcing solutions allow broker-dealers to outsource certain administrative functions relating to clearing and settlement, from order entry to trade matching and settlement, while maintaining their ability to finance and capitalize their business. Broadridge is! a back- ! and middle-office securities processing platform for North American and global broker-dealers. Provided on an application service provider (ASP) basis, Broadridge's platform is a global market solution, clearing and settling in over 50 countries.

The Company's securities processing solutions automate the transaction lifecycle of equity, mutual fund, fixed income, and option securities trading operations, from order capture and execution through trade confirmation, settlement, custody and accounting. The Company's services facilitate the automation of straight-through-processing operations and enable financial institutions to efficiently and cost-effectively consolidate their books and records, gather and service assets under management, focus on their core businesses, and manage risk. With the Company's multi-currency capabilities, the Company supports trading activities on a global basis.

The Company provides a set of multi-currency systems that support real-time processing of securities transactions in North American equities, options, fixed income securities and mutual funds. Brokerage Processing Services (BPS) is the Company's core multi-currency back-office processing system that supports real-time processing of transactions in the United States markets. The Company also offers a version of BPS for processing Canadian securities. In addition to the Company's BPS offering, the Company provides specialized transaction processing tools and services for small to mid-market financial firms in the United States and Canada that are operated on separate Broadridge technology platforms. The Company's securities processing services can be integrated with the Company's Web-based desktop applications, wealth management tools, enterprise workflow, automated inquiry reporting and record-keeping services.

The Company provides advanced multi-currency transaction processing solutions for institutional and retail securities operations, corporate actions, and business processes ! outsourci! ng services, such as data cleansing. The Company also provides operations outsourcing services relating to a variety of securities clearing, record-keeping, and custody-related functions. The Company's clients execute and clear their securities transactions and engage the Company to perform a number of related administrative back-office functions, such as record-keeping and reconciliations.

The Company's core systems for processing equity, option, and mutual fund transactions in the United States markets can also be combined with the Company's specialized systems for processing fixed income and international securities transactions. These specialized securities processing services can be fully integrated with operations outsourcing services. In addition, its clients can integrate its securities processing and operations outsourcing services with its other services, including the processing of trade confirmations and account statements, delivered in paper or electronically; equity and mutual fund prospectus processing; automated workflow tools that help its clients streamline their securities processing and operations activities, and a suite of wealth management products, including data aggregation tools, end-customer Websites, broker desktop, financial planning and modeling tools, performance reporting and portfolio accounting.

Advisors' Opinion:
  • [By M. Joy, Hayes]

    2. Exclusive access to early voting tallies
    JPMorgan recently gained another advantage over activist shareholders when proxy communications and voting company Broadridge Financial Solutions (NYSE: BR  ) cut off activist investors backing shareholder proposals from information about early voting tallies. This change occurred after trade group Securities Industry and Financial Markets Association, which includes JPMorgan as a member, challenged Broadridge's decision to provide shareholders with this information.

  • [By Sid Riggs]

    Something else that's not commonly understood is that a lot of insider buying and selling occurs as part of stock options offered as compensation. Let's use a recent example from Broadridge Financial Solutions (NYSE: BR) to illustrate this:

  • [By Louis Navellier]

    Portfolio Grader raised ACET stock to an “A” ranking in November, and the stock remains a strong buy at the current price.

    Broadridge Financial Services (BR)

    Broadridge Financial Services (BR) helps the financial services industry communicate with clients and investors, as well as meet their increasingly complex compliance needs.

Best Mid Cap Stocks To Invest In Right Now: Timmins Gold Corp (TGD)

Timmins Gold Corp. (Timmins) is a gold mining and exploration company. The Company is engaged in exploration, mine development and the mining and extraction of precious metals, primarily gold. Its primary asset and material mineral property is the San Francisco Gold Property located in Sonora, Mexico, which includes the Company�� only operating mine (the Mine). Its projects include El Capomo Property, Timm Property, El Picacho Property, Patricia and Norma Property, San Onesimo, Zindy and San Fernando Properties, Quila Property and Cocula Property. El Capomo Property is located in Nayarit State, approximately 50 kilometers east of Puerto Vallarta. It acquired Timm Property by staking a 45,000 hectare land package in the Penasquito area. Patricia and Norma Property consists of approximately 20,000 hectares were staked by the Company and are located in the Municipality of Trincheras, Sonora, Mexico. Its Cocula Property is located approximately 50 kilometers west of Guadalajara, Jalisco. Advisors' Opinion:
  • [By Anthony Mirhaydari]

    I’ve added shares of BAA to my Edge Letter Sample Portfolio.

    Breakout Gold Stocks to Buy: Timmins Gold (TGD)


    Click to Enlarge Timmins Gold (TGD), like the other two gold stocks, is also challenging its 200-day moving average as buyers pour capital into a sector that had been left for dead. An upside breakout here would be the first since early 2013.

Best Mid Cap Stocks To Invest In Right Now: SPDR EURO STOXX 50 ETF (FEZ)

SPDR DJ Euro Stoxx 50 ETF (the Fund), formerly DJ Euro Stoxx 50 ETF, seeks to replicate as closely as possible the price and yield of the Dow Jones EURO STOXX 50 Index (the Index). The Index seeks to provide a blue-chip representation of the market sector leaders in the Eurozone. The Index represents the performance of the 50 largest companies within the Eurozone portion of the Dow Jones STOXX Total Market Index. The Index is a free-float market capitalization weighted index that captures approximately 60% of the underlying market and covers approximately 95% of the free-float market capitalization of the investable universe in the Eurozone.

The Fund utilizes a passive or indexing approach to invest in a portfolio of stocks to replicate the Index. The Fund�� investment advisor is SSgA Funds Management, Inc.

Advisors' Opinion:
  • [By Chris Ciovacco]

    In Thursday's ETF analysis, evidence is presented that supports increasing demand for assets that get a tailwind from a weak U.S. dollar, including emerging markets (EEM) and foreign stocks (EFA). Casting a wider economic net, our market model told us to start buying stocks last week even with the threat of a U.S. default. Wednesday, we continued with our incremental allocation shifts by adding some exposure to the energy sector. Thursday, we sat tight holding long positions in small caps (IJR), Europe (FEZ), emerging markets and technology (QQQ). The upper bounds of the bullish S&P 500 trend channel shown below may offer some resistance to the market's near vertical ascent.

  • [By Tom Aspray]

    The news out of the Eurozone continues to improve as their Purchasing Managers Index rose to 51.7 in August consistent with an expanding economy. The chart shows a nice trend here suggesting that the worst by indeed be over. A deeper pullback in some of the euro ETFs like SPDR Euro STOXX 50 ETF (FEZ) should create a buying opportunity.

Best Mid Cap Stocks To Invest In Right Now: Protalix Biotherapeutics Inc (PLX)

Protalix BioTherapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system, ProCellEx. Using its ProCellEx system, the Company is developing a pipeline of biosimilar or generic versions of recombinant therapeutic proteins based on its plant cell-based expression technology, which focuses pharmaceutical markets and that rely upon known biological mechanisms of action. ProCellEx protein expression system consists of a set of technologies and capabilities for the development of recombinant proteins, including advanced genetic engineering technology and plant cell-based protein expression methods. Its ProCellEx protein expression system is built on flexible custom-designed bioreactors made of polyethylene and optimized for the development of complex proteins in plant cell cultures. In June 2010, it had completed the preliminary phase I clinical trial of PRX-105.

Taliglucerase Alfa

Taliglucerase alfa is a plant cell expressed recombinant glucocerebrosidase enzyme (GCD) for the treatment of Gaucher disease. The Company has commenced pre-clinical studies of an oral form of taliglucerase alfa. Its oral taliglucerase alfa is a plant cell expressed form of GCD that is naturally encapsulated within carrot cells genetically engineered to express the GCD enzyme. Pre-clinical studies of oral taliglucerase alfa demonstrate the stability of the enzyme in the cell and the capacity of the cell�� cellulose wall to protect the enzyme against degradation in the digestive tract in an in-vitro model of the stomach and intestines. Additionally, rats fed with lyophilized carrot cells expressing GCD have accumulated the active enzyme in the target organs; the spleen and liver. As of December 31, 2010, the Company had completed Phase III Clinical Trial.

PRX-102

The Company is developing PRX-102, its plant cell expressed modified version of the recombinant ! alpha-GAL-A protein, a therapeutic enzyme for the treatment of Fabry disease. Fabry disease is a rare, hereditary, genetic lysosomal storage disorder in humans caused by an X-lined deficiency of the alpha-GAL-A enzyme. The Company is in the animal evaluation testing phase of the development of PRX-102, which tests are based on a mouse model for Fabry disease.

Acetylcholinesterase

Protalix Ltd. is a wholly owned subsidiary of the Company is licensed the rights to certain technology under a research and license agreement with Yissum Research and Development Company (Yissum) and the Boyce Thompson Institute, Inc. Pursuant to the agreement, the Company is developing PRX-105, a plant cell-based acetylcholinesterase (AChE) and its molecular variants for the use in several therapeutic and prophylactic indications, as well as in a biodefense program and an organophosphate-based pesticide treatment program.

As of December 31, 2010, its in-vitro experiments of PRX-105 have shown that the acetylcholinesterase enzyme in its ProCellEx protein expression system demonstrates biological activity on biochemical and cellular levels. In addition, early animal studies demonstrated that the acetylcholinesterase expressed in its ProCellEx protein expression system was able to treat animals exposed to the nerve gas agent analogues, both when injected with its acetylcholinesterase product candidate immediately before exposure or when injected after exposure. In March 2010, it initiated a preliminary phase I clinical trial of PRX-105, which the Company completed in June 2010.

pr-antiTNF

pr-antiTNF is a candidate for the treatment of certain autoimmune diseases such as rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing, spondylitis, psoriatic arthritis and plaque psoriasis. The Company has designed the antiTNF as pr-antiTNF. pr-antiTNF is a plant cell-expressed recombinant fusion protein made from the soluble form of the human TNF receptor (TNFR), f! used to t! he Fc component of a human antibody domain. pr-antiTNF has an identical amino acid sequence to Enbrel and its in-vitro and preclinical animal studies have demonstrated that pr-antiTNF exhibits similar activity to Enbrel. Specifically, pr-antiTNF binds TNF thereby inhibiting it from binding to cellular surface TNF receptors and protects L929 cells from TNF-induced apoptosis in a dose-dependent manner.

The Company competes with Genzyme, Actelion, Crucell N.V., Biolex, Inc., Chlorogen, Inc., Greenovation Biotech GmbH, Symbiosys, Novartis AG/Sandoz Pharmaceuticals, BioGeneriX AG, Stada Arzneimittel AG, BioPartners GmbH and Teva.

Advisors' Opinion:
  • [By Keith Speights]

    Other investors might wish that Pfizer would use some of its cash to acquire a few smaller companies. Protalix BioTherapeutics (NYSEMKT: PLX  ) has been mentioned as one possible candidate. The two companies already partner together on Gaucher disease drug Elelyso. In February, Protalix spurred rumors that Pfizer could be interested in buying the company after it announced that it had engaged Citigroup to pursue a "broad array of strategic alternatives."

  • [By Maxx Chatsko]

    Industrial biotech isn't the only industry headed to Brazil. Protalix (NYSEMKT: PLX  ) entered into a technology transfer agreement with Brazil's Ministry of Health last week that will pay the company $280 million. The deal is big news for Protalix's first product, Elelyso/Uplyso, which was developed with partner Pfizer (NYSE: PFE  ) . The treatment is approved as an enzyme replacement therapy, or ERT, for adults with type 1 Gaucher disease, and it marks a huge step forward for the future of biomanufacturing. In the following video, Fool contributor Maxx Chatsko explains what this means for the product's commercialization and the adoption of Protalix's novel plant cell-based expression system for therapeutic proteins.

Best Mid Cap Stocks To Invest In Right Now: F5 Networks Inc.(FFIV)

F5 Networks, Inc. provides application delivery networking technology that optimizes the delivery of network-based applications, and the security, performance, and availability of servers, data storage devices, and other network resources in the Americas, EMEA, Japan, and the Asia Pacific. The company offers BIG-IP, an application delivery controller; VIPRION, a chassis-based application delivery controller; and FirePass, an appliance that provides SSL VPN access for remote users of Internet protocol networks, and applications connected to the networks from Web browser on any device. It also offers Application Security Manager, an application firewall; WebAccelerator that speeds Web transactions by optimizing individual network object requests, connections, and end-to-end transactions from browser to databases; WAN Optimization Manager, which integrates application delivery with WAN optimization technologies; Access Policy Manager that provides secure, granular, and contex t-aware control of access to applications; Edge Gateway, a remote access product, which offers context-aware, policy controlled, and remote access to applications at LAN speed; Enterprise Manager that allows customers to discover and view company?s products in a single window; and ARX product family, a series of high performance and enterprise-class intelligent file virtualization devices. In addition, F5 Networks provides Data Manager, a software product, which interfaces with file storage devices; iControl, an application programming interface that allows customers to control their products in the network; iRules, a programming language embedded in TMOS architecture; and consulting, training, maintenance, and other technical support services. The company sells its products to enterprise customers and service providers through various channels, including distributors, value-added resellers, and systems integrators. F5 Networks, Inc. was founded in 1996 and is headquartered in Seattle, Washington.

Advisors' Opinion:
  • [By Hilary Kramer]

    A recent pullback on a small guidance miss at F5 Networks (FFIV) is giving us a good entry point that I want us to take advantage of ahead of strong growth catalysts.

  • [By Lee Jackson]

    F5 Networks Inc. (NASDAQ: FFIV) had truly become an out-of-favor stock recently. It blew away earnings, and the stock responded well. Despite some continued weakness in telecom spending, the rest of the year looks very positive for the company. The consensus price objective stands at $95.

  • [By Dan Caplinger]

    Still, arguably the bigger concern is weakness in IT spending overall. In early April, Cisco fell in sympathy when F5 Networks (NASDAQ: FFIV  ) announced that it expected first-quarter sales to fall well short of analyst expectations, as revenue from both government spending and the telecommunications industry was particularly weak. Cisco has done its best to emphasize the virtual cloud-computing side of its business with its software-defined data center area, but as rivals gravitate toward the tech segments with higher growth potential, Cisco will have to work hard to catch up and surpass the head-starts that better-established companies in the space already have.

  • [By Dan Caplinger]

    Investors shouldn't automatically conclude that the problem is specific to Riverbed, though. Networking peer F5 Networks (NASDAQ: FFIV  ) had to give unfavorable revenue guidance for the remainder of the year when it released its own earnings earlier this week. Moreover, Juniper Networks (NYSE: JNPR  ) sported falling sequential revenue, and guided the current quarter toward the low end of sales expectations. A tough spending environment has made it hard for any networking players to hold their own.

Best Mid Cap Stocks To Invest In Right Now: LipoScience Inc (LPDX)

LipoScience, Inc., incorporated on June 15, 2000, is a vitro diagnostic company. The Company�� diagnostic test, the nuclear magnetic resonance (NMR) LipoProfile test, directly measures the number of low density lipoprotein (LDL), particles in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease. As of January 25, 2013, over eight million NMR LipoProfile tests were ordered. The Vantera system is its automated clinical analyzer. In August 2012, the Company received Food and Drug Administration (FDA) clearance to market the Vantera system commercially to laboratories.

The Company's technology platform combines signal processing algorithms and NMR spectroscopic detection into a clinical analyzer to identify and quantify concentrations of lipoproteins and, potentially, small molecule metabolites. The Company�� Vantera system is the Company's automated clinical analyzer. The Company's NMR LipoProfile test has been cleared by the FDA for use in the Company's clinical laboratory and directly measures LDL-P for use in managing cardiovascular risk.

Advisors' Opinion:
  • [By John Kell and Lauren Pollock var popups = dojo.query(".socialByline .popC"); ]

    LipoScience Inc.(LPDX) on Friday cut its revenue outlook for the current period after its pact with customer Health Diagnostics Laboratory Inc. was terminated. The medical-test provider said it expects the contract termination to weigh on revenue in the short and medium term.

Best Mid Cap Stocks To Invest In Right Now: ING Groep NV (ISP)

ING Groep N.V. (ING) is a global financial institution offering banking, investments, life insurance and retirement services to meet the needs of the customers. The Company�� segments include banking and insurance. Banking segment includes retail Netherlands, retail Belgium, ING direct, retail central Europe (CE), retail Asia, commercial banking (excluding real estate), ING real estate and corporate line banking. Insurance segment includes insurance Benelux, insurance central and rest of Europe (CRE), insurance United States (US), Insurance US closed block VA, insurance Asia/Pacific, ING investment management (IM) and corporate line insurance. In November 2013, the Company completed the sale of ING Hipotecaria to Banco Santander (Mexico), S.A. In December 2013, the Company completed the sale of its 33.3% interest in China Merchants Fund to its joint venture partners China Merchants Bank Co Ltd and China Merchants Securities Co Ltd, and divested ING Life Korea to MBK Partners. Advisors' Opinion:
  • [By Tom Stoukas]

    UniCredit SpA and Intesa Sanpaolo SpA (ISP), Italy�� biggest banks, dropped more than 1 percent as the nation�� benchmark FTSE MIB Index slid 1.2 percent. Rio Tinto Group led mining companies lower after a measure of Chinese manufacturing missed a preliminary estimate. Aryzta AG rallied the most in six months as the Swiss supplier of bakery products reported results that topped projections.

No comments:

Post a Comment